JENNIFER WILKIE: Open Payments
NPI 1215582812 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,648 in 147 payments from 30 companies in 2025. Trend: 2023 $1,307 · 2024 $2,711 · 2025 $3,648
Food & beverage: $3,648
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 14 | $500 |
| Xeris Pharmaceuticals, Inc. | 13 | $297 |
| Novo Nordisk Inc | 13 | $294 |
| RECORDATI_RARE_DISEASES_INC. | 9 | $242 |
| Dexcom, Inc. | 3 | $238 |
| BETA BIONICS, INC. | 7 | $235 |
| Corcept Therapeutics | 16 | $212 |
| Lilly USA, LLC | 9 | $205 |
| Amgen Inc. | 9 | $158 |
| SANOFI-AVENTIS U.S. LLC | 4 | $153 |
Products named: Omnipod, ISTURISA, iLet Bionic Pancreas, Korlym, RECORLEV, DEXCOM G7 GSS (161), MOUNJARO, TZIELD.
Industry payments across SC — which companies pay providers there.
